SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer. [electronic resource]
Producer: 20170802Description: 84-88 p. digitalISSN:- 1095-9203
- Androgen Antagonists -- therapeutic use
- Benzamides
- Cell Line, Tumor
- Cell Lineage
- Cell Plasticity
- Humans
- Male
- Nitriles
- Phenylthiohydantoin -- analogs & derivatives
- Prostatic Neoplasms -- drug therapy
- Retinoblastoma Binding Proteins -- genetics
- SOXB1 Transcription Factors -- genetics
- Tumor Suppressor Protein p53 -- genetics
- Ubiquitin-Protein Ligases -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.